We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Detecto

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.
16 Feb 2023 - 18 Feb 2023

Adjustable Transobturator Effectively Treats Male Incontinence

By Daniel Beris
Posted on 07 Dec 2016
Print article
Image: The ATOMS device with the scrotal port (Photo courtesy of AMI).
Image: The ATOMS device with the scrotal port (Photo courtesy of AMI).
An innovative implantable system with no mechanical parts provides an effective treatment for mild to severe male stress urinary incontinence (SUI).

The adjustable transobturator male system (ATOMS) is a long-term, adjustable implant designed to treat male SUI, generally following invasive treatment of the prostate gland. The implant is based on a suburethral substitute sphincter cushion that provides a gentle, evenly distributed pressure on the bulbospongiosus muscle in order to reduce the risk of urethral erosion. There is no specific point of maximum compression on the urethra, and patients can urinate freely, without having to activate a mechanical component.

The cushion is located in the middle of a mesh fixation tape, with integrated mesh arms that are drawn back around to the middle of the implant and over the inferior pubic ramus to secure the system in place, providing 4-point-fixation that eliminates the need for fasteners or screws. The macroporous mesh integrates into the bone, leading to an extra firm hold. Tissue ingrowth and revascularization of the surrounding tissue reduce the risk of an infection spreading in the pelvis operatively or post-operatively.

Following placement, the substitute sphincter cushion is filled via a scrotal port-catheter connection; the patient-specific adjustments require no further surgical intervention, and can be made at any time to counteract either continuing incontinence or urinary retention. From then on, the ATOMS cushion exerts gentle compression pressure on the bulbospongiosus muscle, and thus indirectly of the urethra, increasing urethral resistance. Involuntary loss of urine is thus reduced or ideally avoided. The ATOMS device is a product of the Agency for Medical Innovations (AMI; Feldkirch, Austria).

“The ATOMS device is safe and shows high treatment efficacy and patient satisfaction in the largest cohort study to date,” said Alexander Friedl, MD, of Hospital Göttlicher Heiland (Vienna, Austria), who led a recent international study of the device. “The latest generation, with its pre-attached silicone-covered scrotal port, is superior to its predecessors. Significantly better results were achieved with primary implantation and in those without a history of radiotherapy.”

In men, SUI usually results from a procedure to remove an enlarged prostate that causes difficulty in urinating. The resulting surgical damage to the urinary sphincter leads to incontinence, or creates functional problems. When the strength of the sphincter muscle is compromised, urine may leak through the urethra. Under pressure to the bladder, such as with a golf swing or a sneeze, leakage may be slight. However, depending on the severity of damage, the impaired sphincter could allow a steady stream of urine.

Related Links:
Agency for Medical Innovations
Hospital Göttlicher Heiland
New
Gold Supplier
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Medical Software
Bladder Scanner Graphics Workstation Software
New
High Frequency X-Ray Generator
SHFR
New
Analgesic Gas Delivery System
O-Two Equinox Advantage

Print article

Channels

AI

view channel
Image: A novel research study moves the needle on predicting coronary artery disease (Photo courtesy of Pexels)

AI-Enabled ECG Analysis Predicts Heart Attack Risk Nearly as well as CT Scans

Increased coronary artery calcium is a marker of coronary artery disease that can lead to a heart attack. Traditionally, CT scans are used to diagnose buildup of coronary artery calcium, although CT scanners... Read more

Critical Care

view channel
Image: The new biomaterial heals tissues from the inside out (Photo courtesy of UC San Diego)

Groundbreaking Biomaterial Injected Intravenously Repairs Cells and Tissue Damaged by Heart Attack and TBI

Following a heart attack, there is development of scar tissue, which affects muscle function and can result in congestive heart failure. However, there is still no established treatment available for repairing... Read more

Health IT

view channel
Image: Using digital data can improve health outcomes (Photo courtesy of Unsplash)

Electronic Health Records May Be Key to Improving Patient Care, Study Finds

When a patient gets transferred from a hospital to a nearby specialist or rehabilitation facility, it is often difficult for personnel at the new facility to access the patient’s electronic health records... Read more

Point of Care

view channel
Image: Steripath improves the diagnostic accuracy and timeliness of sepsis test results (Photo courtesy of Magnolia)

All-in-One Device Reduces False-Positive Diagnostic Test Results for Bloodstream Infections

Blood cultures are considered the gold standard diagnostic test for the detection of blood stream infections, such as sepsis. However, positive blood culture results can be frequently wrong, and about... Read more

Business

view channel
Image: The global patient positioning systems market is projected to reach USD 1.7 billion by 2027 (Photo courtesy of Pexels)

Global Patient Positioning Systems Market Driven by Increasing Chronic Diseases

The global patient positioning systems market is projected to grow at a CAGR of 4% from USD 1.4 billion in 2022 to USD 1.7 billion by 2027, driven by increasing technological advancements in medical devices,... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.